Research finds Kardia Mobile an effective at-home EKG

Anicka Slachta | | Cardiovascular Business | Heart Rhythm

A handful of independent studies have reportedly proven the efficacy of AliveCor’s Kardia Mobile device, a cell phone-compatible gadget that serves as a personal electrocardiograph, for individuals with atrial fibrillation (AFib).

MedPage Today reported large-cohort studies conducted in China were able to demonstrate the tool’s abilities, including successful diagnoses of previously undiagnosed AFib patients with Kardia Mobile’s 30-second EKG test. One study out of the Cleveland Clinic stated Kardia Mobile’s accuracy was “similar to that of a physician” and “lessened AFib-diagnosis anxiety.”

According to AliveCor’s website, anyone can check their heart rate with the device by placing their fingertips on two small sensory pads, which send data to a connected mobile phone and detect any irregularities in heart rhythm. Patients can then save and store recordings, or send them to their doctor via email.

The findings of the recent studies proving Kardia Mobile’s effectiveness were presented at the 2017 ESC Congress in Barcelona.

Read the full MedPage story here:

AliveCor studies show value for atrial fibrillation screening

""
Anicka Slachta

After graduating from Indiana University-Bloomington with a bachelor’s in journalism, Anicka joined TriMed’s Chicago team in 2017 covering cardiology. Close to her heart is long-form journalism, Pilot G-2 pens, dark chocolate and her dog Harper Lee.

Related Content

LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Eko Health’s AI platform for digital stethoscopes granted new CPT code
Predicting sudden cardiac death after a heart attack may be impossible—for now
Concomitant ablation surgery during heart operations boosts long-term survival
Johnson & Johnson MedTech gains FDA approval for Varipulse PFA system
Boston Scientific agrees to acquire AFib ablation company

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."